A group of researchers at the Karolinska Institutet in Stockholm has discovered in a new study recently that antidepressants taken by pregnant women are not the cause of increased risk of newborn deaths or stillbirth.
The team has opened a room for controversy over the matter. Since, earlier studies have discovered a total opposite that these drugs may lead to raised risks of complications during pregnancy.
More than 1.6 million births from five different Nordic countries were studied. Including some 30,000 women, who had all been prescribed an SSRI or selective serotonin reuptake inhibitor during their pregnancy, the study found that there was only a 1.79% hike in rates of stillbirth and post-neonatal death in mothers exposed to an SSRI.
These women showed 4.62 versus 3.69 per 1000 rate of stillbirth and that of post-neonatal death was 1.38 versus 0.96 per 1000. It is being said that the higher rates were the consequences of their underlying psychiatric disease i. e. depression rather than the drugs treating the same.
The team says that cigarette smoking by women with their advanced age were also partly responsible. "Decisions regarding use of SSRIs during pregnancy must take into account other pre-natal outcomes and the risks associated with maternal mental illness", Olof Stephansson and colleagues affirmed.
Good News USA
- Vodafone NZ’s new ‘Red Home’ packages will offer UFB and 150 TV channels
- Vodafone NZ’s full-year profit plunged by more than two-thirds to $56 million
- Vodafone adding 34 European countries to ‘AU$5 per day’ international roaming option
- Telstra launches its new ‘Every Day Connect Data Share Packages’
- Voyager signs “multimillion-dollar deal” with submarine cable group Hawaiki